Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
LH

LH - Laboratory Corp of America Holdings Stock Price, Fair Value and News

$268.10-3.02 (-1.11%)
Market Closed

53/100

LH

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

53/100

LH

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$258.13

Target 3M

$264.53

Target 6M

$262.39

LH Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

LH Price Action

Last 7 days

-0.4%

Last 30 days

6.0%

Last 90 days

6.3%

Trailing 12 Months

7.9%

LH RSI Chart

LH Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

LH Valuation

Market Cap

22.2B

Price/Earnings (Trailing)

25.99

Price/Sales (Trailing)

1.61

Price/Free Cashflow

16.1

LH Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$258.13

Target 3M

$264.53

Target 6M

$262.39

LH Fundamentals

LH Revenue

Revenue (TTM)

13.8B

Rev. Growth (Yr)

8.58%

Rev. Growth (Qtr)

1.03%

LH Earnings

Earnings (TTM)

855.2M

Earnings Growth (Yr)

54.22%

Earnings Growth (Qtr)

9.75%

LH Profitability

Operating Margin

28.45%

Return on Equity

9.83%

Return on Assets

4.68%

Free Cashflow Yield

6.21%

LH Investor Care

Buy Backs (1Y)

0.88%

Diluted EPS (TTM)

10.2

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202513.2B13.5B13.8B0
202412.3B12.5B12.7B13.0B
202313.0B13.1B13.3B12.2B
20229.6B8.7B7.5B10.6B
202118.1B19.2B22.3B13.1B
202010.9B10.2B9.5B16.8B
201911.4B11.4B11.5B11.6B
201810.7B11.1B11.3B11.3B
20179.6B9.7B9.9B10.3B
201616.5B16.7B16.8B16.8B
20156.4B7.1B7.9B8.7B
201410.4B10.4B10.5B10.6B
20135.7B5.7B5.8B5.8B
20125.6B5.6B5.6B5.7B
20115.2B5.3B5.5B5.5B
20100005.0B
Get all data in R, Python etc through our Historical Stock Data APIs

About Laboratory Corp of America Holdings

LH
Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics and Labcorp Drug Development. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications to enable patients to check test results; and online applications for MCOs and accountable care organizations; and end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves MCOs, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
 CEO
 WEBSITElabcorp.com
 SECTORHealthcare
 INDUSTRYDiagnostics & Research
 EMPLOYEES60000

Laboratory Corp of America Holdings Frequently Asked Questions

LH is the stock ticker symbol of Laboratory Corp of America Holdings. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Laboratory Corp of America Holdings is 22.23 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check LH's fair value in chart for subscribers.

The fair value guage provides a quick view whether LH is over valued or under valued. Whether Laboratory Corp of America Holdings is cheap or expensive depends on the assumptions which impact Laboratory Corp of America Holdings's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LH.

As of Wed Jan 28 2026, LH's PE ratio (Price to Earnings) is 25.99 and Price to Sales (PS) ratio is 1.61. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LH PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Laboratory Corp of America Holdings has provided 0.108 (multiply by 100 for percentage) rate of return.